Guideline-concordant treatment and clinical outcomes in older patients with endometrial cancer in Japan: a retrospective single-institution study

BACKGROUND: To evaluate achievement of Japanese guideline-concordant treatment (J-GCT) and examine its association with clinical outcomes among older patients with endometrial cancer. METHODS: We retrospectively reviewed 130 patients aged ≥ 70 years diagnosed between 2010 and 2019. J-GCT was defined as receipt of primary surgery, standard surgical staging including lymph node assessment when indicated, and risk-adapted adjuvant chemotherapy. Progression-free survival (PFS) and overall survival (OS) were analyzed using Kaplan-Meier methods and log-rank tests. Multivariable Cox models evaluated factors associated with PFS. RESULTS: J-GCT achievement was significantly lower in patients aged ≥ 75 years than in those aged 70-74 years (28.1% vs. 71.2%, P < 0.001). Patients aged ≥ 75 years less frequently underwent primary surgery (84.2% vs 97.3%, P = 0.011) and lymph node assessment (45.8% vs 80.3%, P < 0.001). Adjuvant chemotherapy for intermediate- or high-risk disease was less frequently administered in patients aged ≥ 75 years (38.7% vs 86.4%, P < 0.001). Perioperative complications were infrequent, and no treatment-related deaths were observed. J-GCT achievement was associated with improved PFS (P < 0.001) and OS (P = 0.004). In multivariable analysis adjusting for age and selected clinicopathologic factors, failure to achieve J-GCT remained associated with inferior PFS (adjusted hazard ratio 3.20, 95% confidence interval 1.43-7.15; P = 0.005). CONCLUSION: J-GCT achievement was lower among patients aged ≥ 75 years, particularly with respect to lymph node assessment and risk-adapted adjuvant chemotherapy. Failure to achieve J-GCT was associated with inferior PFS after adjustment, although this group included heterogeneous treatment patterns with potentially different prognostic implications. These findings support treatment decision-making based on structured clinical evaluation rather than chronological age alone.

Authors

Institutions

Publication Details

Journal
International Journal of Clinical Oncology
Published
2026-07-23
DOI
https://doi.org/10.1007/s10147-026-03113-z
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Guideline-concordant treatment and clinical outcomes in older patients with endometrial cancer in Japan: a retrospective single-institution study

Kenjiro Sawada, Kae Hashimoto, Michiko Kodama, Tsuyoshi Takiuchi et al.
International Journal of Clinical Oncology
Endometrial and Cervical Cancer Treatments
article

Guideline-concordant treatment and clinical outcomes in older patients with endometrial cancer in Japan: a retrospective single-institution study

Kenjiro Sawada, Kae Hashimoto, Michiko Kodama, Tsuyoshi Takiuchi, K. Kasuya, Satoshi Nakagawa, E Kobayashi, Yutaka Ueda, Naoko Komura
article en

Abstract

BACKGROUND: To evaluate achievement of Japanese guideline-concordant treatment (J-GCT) and examine its association with clinical outcomes among older patients with endometrial cancer. METHODS: We retrospectively reviewed 130 patients aged ≥ 70 years diagnosed between 2010 and 2019. J-GCT was defined as receipt of primary surgery, standard surgical staging including lymph node assessment when indicated, and risk-adapted adjuvant chemotherapy. Progression-free survival (PFS) and overall survival (OS) were analyzed using Kaplan-Meier methods and log-rank tests. Multivariable Cox models evaluated factors associated with PFS. RESULTS: J-GCT achievement was significantly lower in patients aged ≥ 75 years than in those aged 70-74 years (28.1% vs. 71.2%, P < 0.001). Patients aged ≥ 75 years less frequently underwent primary surgery (84.2% vs 97.3%, P = 0.011) and lymph node assessment (45.8% vs 80.3%, P < 0.001). Adjuvant chemotherapy for intermediate- or high-risk disease was less frequently administered in patients aged ≥ 75 years (38.7% vs 86.4%, P < 0.001). Perioperative complications were infrequent, and no treatment-related deaths were observed. J-GCT achievement was associated with improved PFS (P < 0.001) and OS (P = 0.004). In multivariable analysis adjusting for age and selected clinicopathologic factors, failure to achieve J-GCT remained associated with inferior PFS (adjusted hazard ratio 3.20, 95% confidence interval 1.43-7.15; P = 0.005). CONCLUSION: J-GCT achievement was lower among patients aged ≥ 75 years, particularly with respect to lymph node assessment and risk-adapted adjuvant chemotherapy. Failure to achieve J-GCT was associated with inferior PFS after adjustment, although this group included heterogeneous treatment patterns with potentially different prognostic implications. These findings support treatment decision-making based on structured clinical evaluation rather than chronological age alone.

International Journal of Clinical Oncology
Oita University (JP), Wakayama Medical University (JP), Ehime University (JP), The University of Osaka (JP)
Osaka University
Peace, Justice and strong institutions
Openalex Percentile: Top 7%
Endometrial and Cervical Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.